November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreOctober 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.24 billion in 2024 to USD 12.07 billion by 2034, experiencing a CAGR of 8.7%. In 2024, North America led the market, while Asia-Pacific is set for the fastest growth ahead. Cholinesterase inhibitors dominated by product, but pipeline drugs are expected to gr...
November 01, 2025
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV...
November 01, 2025
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and research. It enables early detection through advanced analysis, allowing for timely intervention. AI also a...
November 01, 2025
According to market projections, the global multiple sclerosis diagnosis and treatment market, valued at USD 22.89 billion in 2024, is anticipated to reach USD 31.98 billion by 2034, growing at a CAGR of 3.4% over the next decade. Advancements in technology aid early diagnosis and better prevention for multiple sclerosis (MS), reducing its economic...
November 01, 2025
Market insights predict the global cervical spondylosis diagnosis and treatment industry will increase from USD 6.63 billion in 2024 to USD 12.67 billion by 2034, achieving a CAGR of 6.7%. In 2023, medications dominated the Cervical Spondylosis Diagnosis & Treatment Market with a 38% share, while hospital pharmacies led with 40%. The Asia Pacif...
November 01, 2025
Based on market forecasts, the osteoarthritis sector will expand from USD 9.32 billion in 2024 to USD 20.88 billion by 2034, experiencing a CAGR of 8.4%. In 2023, knee osteoarthritis led the market with a 49% share due to its high prevalence. Imaging tests dominated diagnostics, while North America held a 38% market share. Key players include Zimme...
November 01, 2025
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% share. Bronchodilators dominated treatment options with a 40% share. Hospital pharmacies were the top ...
November 01, 2025
The carpal tunnel syndrome market is growing due to rising cases linked to arthritis, hormonal changes, and more. Innovations like AI improve detection, while ongoing research drives new treatments. Regional trends vary, with North America focusing on awareness and Asia Pacific tackling underdiagnosis challenges....
November 01, 2025
Based on market forecasts, the fibromyalgia treatment sector will expand from USD 2.89 billion in 2024 to USD 4.40 billion by 2034, experiencing a CAGR of 4.3%. The rising demand for Fibromyalgia treatment is driving market growth, with innovative therapies emerging. In 2023, medications led with a 68% market share, while retail pharmacies dominate...
November 01, 2025
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 6.88 billion in 2024, is anticipated to reach USD 16.14 billion by 2034, growing at a CAGR of 8.9% over the next decade. In 2023, medications led the Parkinson’s disease market with a 40% share, while North America dominated at ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com